Treatment of Recurrent Furunculosis With Staphylococcal Bacteriophage-Lysed Vaccine

Richard Bryant, Jay P. Sanford, Tommye Alcoze

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A double-blind evaluation of the effectiveness of a staphylococcal bacteriophage-lysed vaccine in controlling recurrent furunculosis was done on a group of institutionalized school children. A statistically significant decrease in the number of furuncles occurred during the initial phase of study; however, the improvement could not be specifically related to the administration of the vaccine since comparable improvement occurred in children who received broth base as placebo. In the second phase there was no improvement in a group of patients who received vaccine therapy alone.

Original languageEnglish (US)
Pages (from-to)11-14
Number of pages4
JournalJAMA - Journal of the American Medical Association
Volume194
Issue number1
DOIs
StatePublished - Oct 4 1965
Externally publishedYes

Fingerprint

Staphylococcus Phages
Furunculosis
Institutionalized Child
Vaccines
Active Immunotherapy
Placebos
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Treatment of Recurrent Furunculosis With Staphylococcal Bacteriophage-Lysed Vaccine. / Bryant, Richard; Sanford, Jay P.; Alcoze, Tommye.

In: JAMA - Journal of the American Medical Association, Vol. 194, No. 1, 04.10.1965, p. 11-14.

Research output: Contribution to journalArticle

Bryant, Richard ; Sanford, Jay P. ; Alcoze, Tommye. / Treatment of Recurrent Furunculosis With Staphylococcal Bacteriophage-Lysed Vaccine. In: JAMA - Journal of the American Medical Association. 1965 ; Vol. 194, No. 1. pp. 11-14.
@article{13b0db0df15d4fe48c8a833aa1919c3b,
title = "Treatment of Recurrent Furunculosis With Staphylococcal Bacteriophage-Lysed Vaccine",
abstract = "A double-blind evaluation of the effectiveness of a staphylococcal bacteriophage-lysed vaccine in controlling recurrent furunculosis was done on a group of institutionalized school children. A statistically significant decrease in the number of furuncles occurred during the initial phase of study; however, the improvement could not be specifically related to the administration of the vaccine since comparable improvement occurred in children who received broth base as placebo. In the second phase there was no improvement in a group of patients who received vaccine therapy alone.",
author = "Richard Bryant and Sanford, {Jay P.} and Tommye Alcoze",
year = "1965",
month = "10",
day = "4",
doi = "10.1001/jama.1965.03090140019003",
language = "English (US)",
volume = "194",
pages = "11--14",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "1",

}

TY - JOUR

T1 - Treatment of Recurrent Furunculosis With Staphylococcal Bacteriophage-Lysed Vaccine

AU - Bryant, Richard

AU - Sanford, Jay P.

AU - Alcoze, Tommye

PY - 1965/10/4

Y1 - 1965/10/4

N2 - A double-blind evaluation of the effectiveness of a staphylococcal bacteriophage-lysed vaccine in controlling recurrent furunculosis was done on a group of institutionalized school children. A statistically significant decrease in the number of furuncles occurred during the initial phase of study; however, the improvement could not be specifically related to the administration of the vaccine since comparable improvement occurred in children who received broth base as placebo. In the second phase there was no improvement in a group of patients who received vaccine therapy alone.

AB - A double-blind evaluation of the effectiveness of a staphylococcal bacteriophage-lysed vaccine in controlling recurrent furunculosis was done on a group of institutionalized school children. A statistically significant decrease in the number of furuncles occurred during the initial phase of study; however, the improvement could not be specifically related to the administration of the vaccine since comparable improvement occurred in children who received broth base as placebo. In the second phase there was no improvement in a group of patients who received vaccine therapy alone.

UR - http://www.scopus.com/inward/record.url?scp=0002964871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0002964871&partnerID=8YFLogxK

U2 - 10.1001/jama.1965.03090140019003

DO - 10.1001/jama.1965.03090140019003

M3 - Article

C2 - 4220526

AN - SCOPUS:0002964871

VL - 194

SP - 11

EP - 14

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 1

ER -